Company news
Outer Biosciences is pairing living human skin with an AI model
The startup wants repeated experiments on viable human skin to improve predictions about how compounds will behave before clinical testing.
Assembling the brief…
The front page of AI-driven biology.
Topic
General-purpose learned representations for molecules, cells, tissues, and other biological systems.
News
Company news
The startup wants repeated experiments on viable human skin to improve predictions about how compounds will behave before clinical testing.
Company news

Network Bio paired a $50 million launch financing with plans to build a cell-free RNA foundation model alongside NVIDIA.
Company news
GenScript reported that its AI-enabled drug-discovery business doubled year over year, without disclosing standalone segment revenue.
Policy & regulation

A Joint Research Centre report calls for realistic capability claims, transparent reporting, and reproducible validation of biology AI systems.
Research
Mathur and colleagues fine-tuned foundation-model gene embeddings and used temporal graph neural networks to distinguish treatment-response patterns across four inflammatory diseases.
Suga and colleagues combined pretrained RNA-language-model representations with contrastive learning to identify coordinated relationships between 5′ and 3′ untranslated regions.
Xi, G. reports that scDisent separates expression-linked and regulation-linked variables instead of compressing multi-omic measurements into one latent space.
Sallam, A. and colleagues report that an unsupervised stress test separated single-cell foundation models that looked nearly equivalent on standard downstream benchmarks.
Joao Sartori and colleagues report that enzymARC tests whether enzyme-function predictors reject structure-guided decoys whose catalytic machinery has been disrupted.
Thi Lan Nguyen and colleagues report that gRASSP combines pretrained RNA representations with lightweight graph refinement for RNA-small molecule binding-site prediction.
Jiedan Xiao and colleagues report that a conditional diffusion model reconstructs plausible single-cell populations from bulk-like expression summaries.
Yuyan Chen reports that a DNA foundation model combines sequence with local and global chromatin accessibility while trying to prevent one modality from overwhelming the representation.
Maximilien Burq and colleagues matched or beat much larger RNA-only models on most reported benchmarks using a small biological foundation model trained with proteomics.
Julie Liliane Daniel and colleagues report that alphaConformers uses structures from related proteins as template hypotheses to steer AlphaFold2 toward alternative conformations.

Alvin Hsu and colleagues report that optiPrime uses a mechanism-based machine-learning model to predict prime-editing outcomes and nominate edits intended to evade mismatch repair.
Yue You and colleagues report that a preprint combines an immune-aging score, a tokenized virtual-cell model, and an agent that revises its own compound-scoring objective.
Products & tools
Insilico Medicine
Insilico Medicine launched an informational webpage and previewed a multi-agent virtual-cell concept that treats biological age as a conditioning variable across several biological scales.
Capital & partnerships
platform agreement
Lundbeck is expanding EVERSANA's AI-enabled platform across marketing, medical communications, market access, and media in its U.S. organization. The companies did not disclose financial terms or product-level performance.
research collaboration
The companies announced a research collaboration using Chai's models for antibody discovery. Targets, disease areas, economics, timelines, and candidate-level results were not disclosed.
research collaboration
Network Bio announced a collaboration combining its longitudinal cell-free RNA datasets with NVIDIA accelerated computing, Parabricks, and BioNeMo Recipes to build a foundation model called Nexus. Financial terms, development milestones, and external validation plans were not disclosed.
series financing
Fund research and large-scale training of next-generation biological foundation models and upgrade the company's Lab-in-the-Loop platform.